VBIX: 8-K · other
Quantum X Labs Inc. (QXL) announced the launch of its 50+ physical qubit neutral-atom quantum computing platform, marking a significant technical milestone in its development roadmap. The platform utilizes proprietary atom cooling technology and dynamically reconfigurable optical tweezer arrays to enable high-fidelity qubit loading and extended coherence times. The company outlined a strategy to scale to thousands of qubits by the end of the first half of 2027, leveraging a pending patented AI-based error correction system (US12294387B2). This hardware-AI co-design aims to reduce computational overhead and establish a pathway toward real-time, fault-tolerant logical qubit operations. This launch strengthens Quantum X Labs’ portfolio across quantum computing, software, and sensing, with applications targeted at aerospace, defense, pharmaceuticals, and cybersecurity. The announcement serves as a positive signal of technological progress for the company, though it remains a forward-looking operational update without immediate financial impact.
VBIX: 8-K · leadership change
Quantum X Labs Inc. (QXL) has appointed Yakov Baranes as co-Chief Executive Officer, effective May 18, 2026, to serve alongside existing CEO Amihay Hadad. Baranes brings 11 years of business strategy experience and recently led the initial activities of Quantum Israel, the company’s wholly owned subsidiary acquired in March 2026. The appointment is part of a broader strategy to position the company as a leader in researching and commercializing quantum solutions across sectors including navigation, drug discovery, and quantum cyber security. Baranes will receive a base salary of NIS 36,000 per month plus NIS 24,000 for services to the subsidiary, with eligibility for bonuses determined by the board. In connection with the acquisition of Quantum Israel, Baranes received 103,373 shares of common stock and pre-funded warrants to purchase 246,387 shares. He may also receive up to an additional 703,710 shares or warrants upon the achievement of certain milestones, aligning his incentives with the company’s long-term growth goals.
VBIX: 8-K · acquisition merger
Quantum X Labs Inc. (QXL) filed an 8-K to provide audited financial statements and unaudited pro forma combined financial information for its acquisition of Quantum X Labs Ltd., which closed on March 4, 2026. The acquisition was accounted for as a business combination, with a total purchase price of approximately $15.9 million, consisting of $10.7 million in stock consideration and a $5.2 million earn-out liability tied to future milestones. The pro forma financials reveal significant financial stress for the combined entity, showing a pro forma net loss of $21.1 million for the year ended December 31, 2025, driven largely by the acquirer's historical losses and the recognition of $14.3 million in goodwill and $1.6 million in intangible assets. The target company, Quantum Israel, reported a net loss of $325,000 for its first year of operations and carries a material uncertainty related to its ability to continue as a going concern, dependent on securing additional financing. The filing also discloses several subsequent events, including a pending transaction where NeuroThera Labs Inc. agreed to acquire a majority stake in CliniQuantum Ltd., a subsidiary of the target, for approximately CAD $9.46 million in stock. Additionally, the target entered into multiple license agreements for its quantum technologies, including gyroscope and atomic clock developments, generating upfront cash payments and future royalty obligations.
After Successful Acquisition: Quantum X Labs Commences Trading Under New Name and New Nasdaq Ticker Symbol “QXL” Today
Formerly known as Viewbix Inc., the company has rebranded to Quantum X Labs Inc. and commenced trading under the new Nasdaq ticker symbol QXL effective today. The transformation follows the March 2026 acquisition of Quantum X Labs Ltd., shifting the corporate focus from digital advertising to quantum computing, error correction, and sensing technologies. The new entity will continue to operate legacy advertising subsidiaries while advancing a portfolio of quantum tech units focused on navigation, precision timing, and drug discovery.
Viewbix Announces Corporate Rebranding to Quantum X Labs: an Innovative Quantum and Technologies Company
Viewbix Inc. announced a corporate rebranding to Quantum X Labs Inc., with a ticker symbol change to 'QXL' effective April 30, 2026, marking a strategic pivot to quantum computing technologies while retaining its legacy digital advertising segment. The transformation centers on the wholly-owned subsidiary Quantum X Labs Ltd., acquired in March 2026, which houses a portfolio of companies focused on navigation, precision timing, quantum algorithms, and cybersecurity. Notable portfolio holdings include 40% ownership of Quantum Gyro and Nuclear Quantum, and 46% ownership of CliniQuantum, alongside wholly-owned subsidiaries Gix Media and Metagramm for the legacy digital and AI businesses.
Viewbix: Quantum X Labs Announces Strategic Milestone in Advancing Quantum-Powered Nuclear Simulation
